Microsoft Corporation (MSFT) Surface Pro Due Out This Month

Page 1 of 2

Microsoft Corporation (NASDAQ:MSFT) has been working hard to try to get its Windows 8 operating system and its new Surface RT tablet computer to make dents in their respective markets, with relatively little success at this point. Instead, there has been some buzz about Windows 8 Professional and the Surface Pro tablet making their debuts, and there are now several reports suggesting that the wait for both of these items is down to mere days rather than weeks or months.

While Windows 8 and the Surface RT tablet were both released in late October, there was a mention at the time that the upgraded Pro version of the OS and tablet would be out about three months afterward. And there are now several reports circulating, according to this story, that Microsoft Corporation (NASDAQ:MSFT) – which is sitting out the International Consumer Electronics Show in Las Vegas this week  –  will be launching its Pro versions somewhere around January 26, though the specific date is not known at this point.

Microsoft Corporation (MSFT) Giving Apple Inc. (AAPL) a Run for its ‘Patent Money’

While it is interesting that Microsoft Corporation (NASDAQ:MSFT) will not have a presence at CES this year – usually, CEO Steve Ballmer is the keynote speaker at this event – Microsoft will be the talk of the show. Actually, Windows 8 in specific will be a noteworthy theme of the show, as app development has been ramping up, and there has been talk of several new tablets coming out that would feature Windows 8 as the OS. Among the noteworthy products being talked about is a Lenovo “coffee table PC,” a giant 27-inch tablet that can lay flat on a table and can be accessed by 10 fingers at once and four people can sit around it.

With such a highly anticipated launch coming, should we wonder why Microsoft is not at CES this week?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!